30 September 2026 · MHRA
MHRA and DIA announce speaker line-up for global summit
The Medicines and Healthcare products Regulatory Agency (MHRA), working in partnership with the Drug Information Association (DIA), has announced the speaker line-up for the inaugural DIA-MHRA Global Summit. The forthcoming event is designed to bring together international healthcare leaders, policymakers, and industry stakeholders to examine some of the most significant opportunities and pressing challenges facing modern healthcare systems worldwide.
According to the announcement, the collaborative summit will provide a high-level forum to address evolving issues across global regulatory practice, medicine development, and patient safety. By coordinating directly with the DIA, the MHRA aims to encourage structured dialogue on shared international priorities, cross-border regulatory alignment, and the ongoing modernisation of healthcare oversight across multiple jurisdictions.
Detailed speaker profiles, individual panel titles, and comprehensive session itineraries were not fully itemised in the regulator's preliminary notice. However, the initiative reflects the UK regulator's sustained emphasis on multilateral engagement, ensuring that domestic standards remain closely informed by broader international developments. Additional updates regarding confirmed presentations, workshop topics, and conference outcomes are expected through official communication channels in due course.
For UK online pharmacies and digital health platforms, insights from the summit may offer useful foresight into upcoming regulatory priorities, though the notice carries no immediate operational requirements.